ES2130069A1 - Preparacion farmaceutica con liberacion retardada del producto activo. - Google Patents
Preparacion farmaceutica con liberacion retardada del producto activo.Info
- Publication number
- ES2130069A1 ES2130069A1 ES09700765A ES9700765A ES2130069A1 ES 2130069 A1 ES2130069 A1 ES 2130069A1 ES 09700765 A ES09700765 A ES 09700765A ES 9700765 A ES9700765 A ES 9700765A ES 2130069 A1 ES2130069 A1 ES 2130069A1
- Authority
- ES
- Spain
- Prior art keywords
- delayed release
- active ingredient
- pharmaceutical preparation
- solvent
- surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Preparación farmacéutica con liberación retardada del producto activo y su empleo para la fabricación de soluciones inyectables para el tratamiento terapéutico de animales, cuya preparación comprende: a)un producto activo, b)un agente formador de gel, c)un tampón, d)una substancia tensioactiva.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9700765A ES2130069B1 (es) | 1997-04-10 | 1997-04-10 | Preparacion farmaceutica con liberacion retardada del producto activo. |
EP98106425A EP0872232A1 (de) | 1997-04-10 | 1998-04-08 | Pharmazeutische Zubereitung mit verzögerter Wirkstofffreigabe |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9700765A ES2130069B1 (es) | 1997-04-10 | 1997-04-10 | Preparacion farmaceutica con liberacion retardada del producto activo. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2130069A1 true ES2130069A1 (es) | 1999-06-16 |
ES2130069B1 ES2130069B1 (es) | 2000-03-01 |
Family
ID=8298911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9700765A Expired - Fee Related ES2130069B1 (es) | 1997-04-10 | 1997-04-10 | Preparacion farmaceutica con liberacion retardada del producto activo. |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP0872232A1 (es) |
ES (1) | ES2130069B1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106309409B (zh) * | 2016-09-29 | 2019-05-24 | 乐山市瑞和祥动物保健药业有限公司 | 一种酒石酸泰乐菌素预混剂组合物的缓释微丸制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE825656A (fr) * | 1974-02-19 | 1975-08-18 | Solution d'oxytetracycline et procede permettant de la preparer | |
US4018889A (en) * | 1976-01-02 | 1977-04-19 | Pfizer Inc. | Oxytetracycline compositions |
GB2136293A (en) * | 1983-03-11 | 1984-09-19 | Richter Gedeon Vegyeszet | Antiinflammatory compositions |
US5075295A (en) * | 1989-12-12 | 1991-12-24 | Boehringer Ingelheim Animal Health, Inc. | Novel oxytetracycline compositions |
WO1994021267A1 (en) * | 1993-03-24 | 1994-09-29 | Norbrook Laboratories Limited | Tylosin containing sustained release veterinary compositions |
WO1996001634A1 (en) * | 1994-07-09 | 1996-01-25 | Norbrook Laboratories Limited | Long-acting oxytetracycline composition |
-
1997
- 1997-04-10 ES ES9700765A patent/ES2130069B1/es not_active Expired - Fee Related
-
1998
- 1998-04-08 EP EP98106425A patent/EP0872232A1/de not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE825656A (fr) * | 1974-02-19 | 1975-08-18 | Solution d'oxytetracycline et procede permettant de la preparer | |
US4018889A (en) * | 1976-01-02 | 1977-04-19 | Pfizer Inc. | Oxytetracycline compositions |
GB2136293A (en) * | 1983-03-11 | 1984-09-19 | Richter Gedeon Vegyeszet | Antiinflammatory compositions |
US5075295A (en) * | 1989-12-12 | 1991-12-24 | Boehringer Ingelheim Animal Health, Inc. | Novel oxytetracycline compositions |
WO1994021267A1 (en) * | 1993-03-24 | 1994-09-29 | Norbrook Laboratories Limited | Tylosin containing sustained release veterinary compositions |
WO1996001634A1 (en) * | 1994-07-09 | 1996-01-25 | Norbrook Laboratories Limited | Long-acting oxytetracycline composition |
Also Published As
Publication number | Publication date |
---|---|
ES2130069B1 (es) | 2000-03-01 |
EP0872232A1 (de) | 1998-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7207098A (en) | Stabilization of acid sensitive benzimidazols with amino acid/cyclodextrin combinations | |
HK1018396A1 (en) | Delivery system of an active agent. | |
AU4617797A (en) | Solid foamed active substance preparations | |
UA72884C2 (uk) | Стабілізовані розчини паратирину | |
PL335575A1 (en) | Hydrophilic two-component systems for use in administration of cyclosporine | |
CA2004598A1 (en) | Medicinal aerosol formulations | |
MX9304975A (es) | Una composicion en polvo para inhalacion y procedimiento para preparar la misma. | |
DK0695172T3 (da) | Fast præparat med hurtig frigørelse, dets fremstilling og dets anvendelse | |
WO1999002133A3 (en) | Topical application of a combination of benzoyl peroxide and a second active ingredient | |
AU1086601A (en) | Formulations for delivery of osteogenic proteins | |
AU698240B2 (en) | Composition providing selective release of an active ingredient | |
HK1040920A1 (en) | Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent. | |
HK1032010A1 (en) | Medicament formulation with a controlled release of an active agent. | |
WO1997028104A3 (de) | Puffersysteme zur stabilisierung pharmazeutischer zubereitungen | |
NO985145D0 (no) | Farmas°ytiske preparater for forsinket frigj°ring av uoppl°selige, aktive bestanddeler | |
ATE262911T1 (de) | Pharmazeutische präparate, insbesondere ovula, die viele verschiedene aktive bestandteile enthalten | |
AU2003269792A1 (en) | Pharmaceutical formulation of olanzapine | |
ES2130069A1 (es) | Preparacion farmaceutica con liberacion retardada del producto activo. | |
HRP20020165B1 (en) | Low-dose tablets and preparation method | |
ES2131482A1 (es) | Formulacion acuosa de bambuterol. | |
AU7467994A (en) | Novel polysaccharide and radioprotective agent containing the same as active ingredient | |
RS50074B (sr) | Farmaceutski preparat koji sadrži paracetamol i drotaverin | |
AU1092095A (en) | Intra-uterine ring for the release of an active agent, such as a hormone, and an introducer | |
ZA9711336B (en) | Sulfonamido or carboamido derivatives and pharmaceutical composition containing them as an active ingredient. | |
AU2001267435A1 (en) | Plaster containing estrogen, with an active agent reservoir based on ethylcellulose, polyoxyethylene lauryl alcohol and an ethylene-vinylacetate-vinylpyrrolidone copolymer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19990616 Kind code of ref document: A1 Effective date: 19990616 |
|
FD1A | Patent lapsed |
Effective date: 20040503 |